Safety, tolerability and pharmacokinetics and pharmacodynamics of HL2351, a novel hybrid fc‐fused interleukin‐1 receptor antagonist, in healthy subjects: A first‐in‐human study
2019 ◽
Vol 44
(5)
◽
pp. 723-724
Keyword(s):
2018 ◽
Vol WCP2018
(0)
◽
pp. PO2-5-18
Keyword(s):
1998 ◽
Vol 5
(1)
◽
pp. 116A-116A
1993 ◽